Kestra Medical Technologies
KMTS
103 hedge funds and large institutions have $1.17B invested in Kestra Medical Technologies in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 22 reducing their positions, and 23 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 22
3.87% more ownership
Funds ownership: 96.23% → 100.1% (+3.9%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
4% less funds holding
Funds holding: 107 → 103 (-4)
21% less capital invested
Capital invested by funds: $1.49B → $1.17B (-$316M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$37.7M |
| 2 |
BlackRock
New York
|
+$10.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$6.89M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.54M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$4.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$8.28M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.56M |
| 3 |
Jennison Associates
New York
|
-$5.82M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.11M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$4.78M |
KMTS Hedge Fund Activity: Q1 2026 in Review
103 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q1 2026, worth a combined $1.17B — down 21% from $1.49B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of KMTS and 22 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 44 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $37.7M. The largest seller was Omega Fund Management, cutting an estimated $8.28M.
- 103 institutional investors held Kestra Medical Technologies (KMTS) as of Q1 2026, down from 107 in Q4 2025.
- Funds reported $1.17B of Kestra Medical Technologies stock for Q1 2026, down 21% quarter-over-quarter.
- 22 funds opened new Kestra Medical Technologies positions in Q1 2026 and 23 closed out, a net change of -1 holder.
- The largest Kestra Medical Technologies buyer in Q1 2026 was T. Rowe Price Associates, an estimated $37.7M added.
- The largest Kestra Medical Technologies seller in Q1 2026 was Omega Fund Management, an estimated $8.28M sold.
Based on aggregated 13F filings for Q1 2026.